Table 1.
Kinases | IC50 (mean ± SD)/nM |
---|---|
EGFR-T790M/L858R | 183.7±30.7 |
EGFR-WT | 2429.0±396.1 |
HER2 | 190.6±66.9 |
HER3 | 160.3±32.2 |
HER4 | 180.1±78.6 |
RET | 279.6±58.6 |
KDR | > 10000.0 |
PDGFR-β | > 10000.0 |
Flt-1 | > 10000.0 |
ABL | > 10000.0 |
EPH-A2 | > 10000.0 |
RON | > 10000.0 |
PDK1 | > 1000.0 |
PDHK2 | > 1000.0 |
PKBα | > 1000.0 |
PI3K (p110α/p85α) | > 1000.0 |
PKAcα | > 1000.0 |
GSK3β | > 1000.0 |
PKCα | > 1000.0 |
PKCβI | > 1000.0 |
PKCβII | > 1000.0 |
PKCδ | > 1000.0 |
PKCε | > 1000.0 |
PKCη | > 1000.0 |
PKCγ | > 1000.0 |
PKCι | > 1000.0 |
PKCμ | > 1000.0 |
PKCν | > 1000.0 |
PKCθ | > 1000.0 |
PKCζ | > 1000.0 |
Note: shown are inhibitory activities of ZWM026 against a variety of kinases using an in vitro ELASA assay or provided by the Kinexus target profiling service. Some values are expressed as IC50 (mean ± SD) from three or more independent experiments.